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Objective: Common variants near melanocortin receptor 4 (MC4R) have been related to fatness and type 2 diabetes. We
examined the associations of rs17782313 and rs17700633 in relation to body fat, body fat distribution, metabolic traits, weight
development and energy expenditure.
Methods: Obese young men (n¼753, BMIX31.0 kgm2) and a randomly selected group (n¼874) identified from a
population of 174800 men were re-examined in three surveys at mean ages 35, 46 and 49 years (S-35, S-46 and S-49).
Measurements were available at upto eight times from birth to adulthood. Logistic regression analysis was used to assess odds
ratio (OR) for the presence of the carrier allele for a given difference in phenotypic values.
Results: Rs17782313 minor C-allele was associated with overall, abdominal and peripheral fatness (range of OR¼1.06–1.14 per
z-score units) at all three surveys, although only consistently significant at S-35 and S-46. Rs17700633 minor A-allele was
also associated with the fatness measures, but significantly so only at S-49 for overall and abdominal fatness (range of
OR¼1.03–1.15 per z-score units), and peripheral fatness (OR¼1.15–1.20 per z-score units). There were only few significant
associations with metabolic traits. The rs17782313 C-allele and the rs17700633 A-allele were both associated with lower high-
density lipoprotein cholesterol (range of OR¼0.64–0.84 permol l1), significantly at S-46. The rs17700633 A-allele was
significantly associated with insulin (OR¼1.25 per 50pmol l1), leptin (OR¼1.42 per 10 ngml1) and insulin sensitivity
(OR¼0.81 per model unit). The rs17782313 C-allele and the rs17700633 A-allele were both associated with BMI in childhood
and adolescence (range of OR¼1.04–1.17 per z-score units), significant for the rs17782313 C-allele at the age of 13–19 years
and for rs17700633 A-allele at age 7, 10, 13 and 19 years. No significant associations were found for energy expenditure.
Conclusion: Near MC4R variants appear to contribute to body fat, body fat distribution, some metabolic traits, weight
development during childhood, but not to energy expenditure.
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Introduction
Within the last couple of years new advanced gene
identification strategies, especially the genome-wide
association studies, have been the main contributors to
success in the gene discoveries of common complex diseases,
such as common obesity.1,2 In the genetics of common
obesity, the discovery of FTO was the first major success of
genome-wide association studies, providing new insight into
the pathogenesis of common obesity.3–5 The melanocortin
receptor 4 (MC4R), located at chromosome 18q22, is involved
in energy expenditure and appetite regulation,6 and is a
compelling candidate gene of obesity, as rare coding muta-
tions consistently have been associated with monogenic
obesity in humans.7–9 In a large-scale genome-wide associa-
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tion studies, two novel common variants, mapping 188kb
(rs17782313; T/C) and 109kb (rs17700633; G/A) downstream
of MC4R, were found to associate with fatness in both adults
and children.10 The minor C-allele of rs17782313 and the
minor A-allele of rs17700633, with a frequency of 0.24 and
0.30 respectively, and a low pair-wise linkage disequilibrium
(LD) (r2¼0.08 in CEU HapMap), have modest allelic associa-
tion with previously reported rare MC4R variants.10 Thus, the
associations between the novel common MC4R variant and
fatness are unlikely to be explained by previously reported
associations of rare MC4R variants with monogenic obesity,
and it remains to be investigated if the nearMC4R variants are
involved in the MC4R pathway. Subsequent genome-wide
association studies in individuals of Indian–Asian and
European ancestry confirmed the associations between novel
common variants near MC4R and fatness.11 Albeit the
identified variants were not identical, the most strongly
associated variant (rs12970134) was in high LD with
rs17782313 (r2¼ 0.81 in CEU HapMap).
In this study, we examined the associations of rs17782313,
rs17700633 and rs12970134 near MC4R with (1) distinct
specific fatness phenotypes and metabolic quantitative
traits, (2) weight development throughout life, using
repetitive assessments at upto eight times from birth to




Among 362200 Caucasian men examined at the mean age
of 20 years at the draft boards in Copenhagen and its
surroundings during 1943–77, a randomly selected group of
1 in every 100 men (n¼3601) and all obese men (n¼1930)
were manually identified. Obesity was defined as 35%
overweight relative to a local standard in use at the time,
and this corresponds to a BMI X31.0 kgm2, which proved
to be above the 99th percentile. All obese and half of the
random sample, still living in the region, were invited to a
follow-up survey in 1982–1984 at the mean age of 35 years
(survey S-35), in 1992–94 at the mean age of 46 years (survey
S-46) and in 1998–2000 at the mean age of 49 years (survey
S-49). The criteria for invitation to the follow-up surveys and
the participation have been described previously,12–14 and
the number of participants shows the expected attrition over
time (Table 1). Phenotypic assessments were carried out at all
surveys, though much more thoroughly at survey S-49. DNA
was sampled from buffy coats at S-46. In total, 1621 (747
obese and 874 randomly selected) participants were geno-
typed for this study, indicating that the randomly selected
group represent 174 800 men, who were originally identified
at the draft board examination. Among these 553 (232 obese
and 321 randomly selected) had been assessed in S-49. From
school health records, anthropometric measurements from
birth and childhood (age 7, 10 and 13 years) were available15
in a subset of the population and linked to the present
cohort study. The Danish Data Protection Agency and the
regional ethical committee approved the study to be in
accordance with the Helsinki Declaration II. All participants
signed a written consent before participating.
Phenotypic measurement
Waist circumference (cm) was measured according to the
WHO recommendations to the nearest 0.5 cm with the
subjects standing, using a nonexpendable linen tape
measure,16 Total body fat mass (kg) was assessed by
bioimpedance at S-46 and from the DEXA scan at S-49.
Fat body mass index (fat-BMI; kgm2) was calculated as
total body fat mass (kg) divided by height (m) squared.
Table 1 Genotype distributions of rs17782313, rs17700633 and rs12970134 near MC4R for controls and obese participants in absolute numbers and percentages
at survey S-35 (n¼1325), S-46 (n¼1621) and S-49 (n¼ 553)
Controls Obese
rs17782313 TT (%) TC (%) CC (%) MAF TT (%) TC (%) CC (%) MAF
S-35 424 (32.4) 286 (51.0) 30 (16.6) 0.23 281 (24.1) 247 (48.1) 44 (27.8) 0.29
S-46 502 (57.7) 328 (37.6) 41 (4.7) 0.24 362 (49.3) 312 (42.3) 62 (8.4) 0.30
S-49 186 (35.6) 117 (47.2) 16 (4.2) 0.23 117 (26.4) 92 (45.0) 21 (28.6) 0.29
rs17700633 GG (%) GA (%) AA (%) GG (%) GA (%) AA (%)
S-35 368 (32.4) 298 (51.0) 77 (16.6) 0.30 260 (24.1) 270 (48.1) 52 (27.8) 0.32
S-46 430 (49.3) 353 (40.3) 91 (10.4) 0.31 322 (43.2) 357 (47.7) 68 (9.1) 0.33
S-49 169 (35.6) 123 (47.2) 29 (17.2) 0.28 100 (26.4) 106 (45.0) 26 (28.6) 0.34
rs12970134 GG (%) GA (%) AA (%) GG (%) GA (%) AA (%)
S-35 388 (54.0) 292 (34.6) 38 (5.4) 0.26 252 (44.4) 263 (46.3) 53 (9.3) 0.33
S-46 454 (53.9) 339 (40.2) 50 (5.9) 0.26 322 (43.9) 337 (45.9) 75 (10.2) 0.33
S-49 176 (56.6) 117 (37.6) 18 (5.8) 0.25 100 (43.6) 108 (47.2) 21 (9.2) 0.33
Abbreviations: MAF, minor allele frequency;MC4R, melanocortin receptor 4. S-35, S-46 and S-49 denote the separate surveys in which participants were examined at
the mean age of 35, 36 and 49 years, respectively.
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Intra-abdominal adipose tissue (cm2) was calculated from
DEXA scans and anthropometry.17 Lower body fat mass (%)
was calculated from DEXA scans as the fat percentage of
lower body fat mass.
Participants in S-35 and S-46 had non-fasting glucose and
lipid levels (high-density lipoprotein (HDL)-cholesterol and
triglycerides) determined on fresh plasma samples. In the
S-49 cohort, an oral glucose tolerance test was conducted,
except in individuals with diagnosed and, therefore, likely
treated diabetes (n¼10).12 Classification of impaired glucose
tolerance (IGT) or type 2 diabetes was done according to the
WHO diagnostic criteria.18 Insulin sensitivity and acute
insulin response were assessed by the recently recommended
BIGTT indices (BIGTT-SI and BIGTT-AIR, respectively) on the
basis of measurements of plasma glucose and serum insulin
at
time points 0, 30 and 120min during the oral glucose
tolerance test.19 Details on data collections and measure-
ment of anthropometric and other phenotypic estimates,
including biochemical variables, have been described else-
where.12,20,21
Molecular genetic analyses
Genotyping of MC4R rs17782313, rs17700633 and
rs12970134 was carried out using Taqman allelic discrimina-
tion (KBioscience, Herts, UK). The genotype success rates
were 97, 95.7 and 94.7%; error rates 0.28% in 721 duplicate
samples, 0% in 196 duplicate samples and 0.18% in 551
duplicate samples for rs17700633, rs17782313 and
rs12970134, respectively. All genotype groups obeyed
Hardy–Weinberg equilibrium.
Statistical methods
A likelihood ratio test for an additive, a dominant and a
recessive effect of the genotyped variants determined that a
dominant genetic model was chosen for all three single-
nucleotide polymorphisms (wild type versus heterozygous
and homozygous genotype).
The data collected at each of the follow-up surveys, S-35,
S-46 and S-49, were analyzed separately for each survey.
The data on the obese and the controls were analyzed
together by applying a logistic regression model. In this
model, the probability of observing the particular genotype
(presence of the minor allele) was defined as the dependent
response variable and the quantitative values of the
phenotypes irrespective of whether the individual originally
belonged to the obese group or the control group. The
massive enrichment of the right tail of the BMI distribution
implies that the data cannot be analysed with BMI or
BMI-associated outcomes conditional on the genotypes (for
example by mean BMI per genotype) or as response variables
in common regression models. Also, using a dichotomized
case–control approach would waste considerable statistical
efficiency otherwise gained by using quantitative phenotypes.
Hence, to take advantage of the greater statistical power and
much wider coverage of the phenotypes, we reversed the
statistical models for the associations and examined the
probability of carrying the particular risk-allele genotype for a
given level of the phenotypes. This can be done without
distributional assumptions about the phenotypes. Thus,
logistic regression analysis was used to assess the odds ratios
(ORs) of the genotype (response variable) in relation to the
phenotypes (covariates) in the combined case and control
groups with and without adjustment for the concurrent
fat-BMI (kgm2). Information for fat-BMI was not available in
S-35, and therefore we adjusted for BMI in these analyses.
To obtain similar fatness units, all anthropometrics and
body composition measures were converted to age-adjusted
z-scores that indicate the deviations from the population
mean values in s.d. units. The age-adjusted z-scores were
calculated from the mean values and s.d. of the randomly
selected control group and applied to the entire study
population. In other words, 1 z-score unit (U) is equal to 1
s.d. of the particular obesity phenotype in the control
sample. In the remainder analyses, age at examination was
included as a continuous covariate. The OR for being carrier
of the minor allele according to BMI z-score should be
interpreted as an increment in odds for being carrier of the
minor allele per U increase in BMI z-score. Nominal P-values
are reported, and the interpretation of them in the light of
multiple testing is included in the Discussion section.
Analyses were carried out using SAS statistical procedures
(version 9.1; SAS Institute Inc, Cary, NC, USA).
Results
The minor allele frequencies of rs17782313, rs17700633 and
rs12970134 near MC4R were almost exactly the same at the
three surveys indicating that the attrition of the study groups
by time was not dependent on the genotype (Table 1). In
controls, the minor allele frequencies of rs17782313,
rs17700633 and rs12970134 were 0.23–0.24, 0.28–0.31 and
0.25–0.26, respectively, almost analogous to the reported
distribution in European Caucasians.10 Rs17782313 and
rs17700633 were in low LD with each other (r2¼0.13),
rs17782313 was in high LD with rs12970134 (r2¼0.75),
whereas rs17700633 was in low LD with rs12970134
(r2¼0.18) in the present study population. All results
obtained for rs12970134 were identical to those obtained
for rs17782313, and are therefore not reported here.
Overall, abdominal and peripheral fatness
We estimated the ORs of the genotype (response variable) in
relation to the phenotypes (covariates). Results from logistic
regression analyses for fatness phenotypes are given in ORs
with 95% confidence intervals.
All obesity-related phenotypes elucidating overall, abdom-
inal and peripheral fatness were associated with rs17782313
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at survey S-35 and S-46 (Table 2), where a 1 U z-score increase
in obesity phenotypes increased the odds for the minor allele
carriers by 6–8% (OR¼1.06–1.08, P¼0.022–0.039). Signifi-
cant associations were observed in relation to hip circum-
ference and lower body fat mass (%) at survey S-49, where a
1-U increase in hip circumference and lower body fat mass
increased the odds for the C-allele carriers by 11–14%
(OR¼1.11–1.14, P¼0.039–0.042). For overall and abdominal
fatness at S-49, estimates were similar to the obtained
estimates at S-46, but did not reach statistical significance.
Compared with rs17782313, we obtained stronger significant
associations between the examined obesity phenotypes and
rs17700633, albeit only at S-49 (Table 2). A 1-U increase in
overall and abdominal fatness increased the odds for the A-
allele by 14–16% (OR¼1.14–1.16, P¼0.006–0.022). For
peripheral fatness, a 1-U z-score increase in hip circumfer-
ence and lower body fat mass (%) increased the odds for the
A-allele by 15–20% (OR¼1.15–1.20, P¼0.004).
The associations between the near MC4R variants and all
body fat measures were weakened when adjusted for fat-BMI,
and neither of these measures nor fat-BMI itself maintained
statistical significance when analysed together (data not
shown).
Metabolic traits
Generally, there were only few statistically significant results
(Table 3). Thus, none of the associations between the MC4R
variants and circulating levels of glucose, C-peptide, HbA1C,
triglyceride, free fatty acids, fibrinogen, ASAT or blood
pressure reached statistical significance.
Both variants near MC4R were associated with serum HDL-
cholesterol levels at S-46, where a 1-U increase in mmol l1
HDL-cholesterol decreased the odds for the rs17782313
C-allele and rs17700633 A-allele by 24 and 28%, respectively
(OR¼0.76, P¼ 0.03 and OR¼ 0.72, P¼0.008, respectively).
Similar estimates were obtained at survey S-35 and S-49, but
they did not reach statistical significance.
At S-49, an association between plasma insulin and
rs17700633 was observed, where each 50-pmol l1 increase
of insulin increased the odds for the A-allele by 25%
(OR¼1.25, P¼0.03) (Table 3). An association between a
surrogate measure of insulin sensitivity and rs17700633 was
obtained. A 1-U increase in BIGTT-SI index decreased the
odds for the A-allele by 19% (OR¼0.81, P¼0.038).
A strong significant association between circulating leptin
levels and rs17700633 was obtained at S-49, where a 10-U
increase in circulating leptin increased the odds for the
A-allele by 42% (OR¼1.42, P¼0.005).
As expected, the significant associations were weakened
when adjusted for fat-BMI (data not shown).
Childhood and adolescence obesity
Except at birth, associations were observed between both
near MC4R variants and BMI z-score during childhood and
adolescence (Table 4). A 1-U increase in BMI z-score
increased the odds for the rs17782313 C-allele by 12 and
7%, respectively at age 13 and 19 years (OR¼1.12, P¼0.034
and OR¼1.07, P¼0.0004, respectively). Associations for age
7 and 10 years showed similar estimates, but were not
significant. A 1-U increase in BMI z-score increased the odds
for the rs17700633 A-allele by 15, 17, 17 and 4%, respectively
at age 7, 10, 13 and 19 years (OR¼1.15, P¼ 0.015; OR¼1.17,
P¼0.005, OR¼1.17, P¼0.005 and OR¼1.04, P¼0.038,
respectively).
Table 2 Odds ratio (OR) including 95% confidence intervals (CI) for MC4R rs17782313 C-allele carriers and for rs17700633 A-allele carriers in relation to fatness
phenotypes (in age-adjusted z-scores)








FBMI (kgm2) F F 1.08 (1.01; 1.15) 0.022 1.07 (0.97; 1.18) 0.207
BMI (kgm2) 1.06 (1.00; 1.12) 0.037 1.07 (1.00; 1.13) 0.038 1.07 (0.97; 1.17) 0.172
Waist (cm) F F 1.08 (1.01; 1.15) 0.025 1.10 (0.99; 1.22) 0.083
IAAT (cm2) F F F F 1.07 (0.96; 1.20) 0.243
Hip (cm) F F 1.07 (1.00; 1.15) 0.039 1.11 (1.01; 1.22) 0.039
LBFM (%) F F F F 1.14 (1.00; 1.28) 0.042
Rs17700633
FBMI (kgm2) F F 1.04 (0.98; 1.11) 0.196 1.15 (1.04; 1.27) 0.007
BMI (kgm2) 1.03 (0.98; 1.09) 0.257 1.04 (0.98; 1.10) 0.244 1.14 (1.03; 1.25) 0.008
Waist (cm) F F 1.05 (0.99; 1.13) 0.121 1.16 (1.04; 1.29) 0.006
IAAT (cm2) F F F F 1.14 (1.02; 1.28) 0.022
Hip (cm) F F 1.04 (0.98; 1.11) 0.231 1.15 (1.05; 1.27) 0.004
LBFM (%) F F F F 1.20 (1.06; 1.36) 0.004
Abbreviations: BMI, body mass index; FBMI, fat body mass index; IAAT, intra-abdominal adipose tissue; LBFM, lower body fat mass. S-35, S-46 and S-49 denote the
separate surveys, in which participants were examined at the mean age of 35, 36 and 49 years, respectively. Within each survey, the obese and the control group
were analysed together by using the phenotype, for example BMI, as covariate in a logistic regression model with odds of the genotype as the response variable.
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Table 3 Odds ratio (OR) including 95% confidence intervals (CI) forMC4R rs17782313 C-allele carriers and for rs17700633 A-allele carriers in relation to metabolic
traits and OGTT-derived indices









p-Glucose (10mmol l1) 1.06 (0.48; 2.35) 0.88 1.03 (0.98; 1.05) 0.38 0.99 (0.29; 0.36) 0.98
s-Insulin (50 pmol l1) F F F F 1.16 (0.96; 1.41) 0.13
s-HDL (mmol l1) 0.74 (0.48; 1.13) 0.16 0.76 (0.60; 0.97) 0.03 0.73 (0.41; 1.32) 0.30
s-Triglycerides (10mmol l1) F F F F 1.89 (0.45; 7.95) 0.39
Systolic BP (10mmHg) 1.02 (0.95; 1.09) 0.61 0.99 (0.93; 1.04) 0.63 0.94 (0.99; 1.01) 0.95
Diastolic BP (10mmHg) 1.02 (0.93; 1.11) 0.72 1.01 (0.92; 1.10) 0.91 0.95 (0.85; 1.04) 0.21
s-C-peptide (500mmol/l) F F F F 1.08 (0.85; 1.37) 0.51
HbA1C (%) F F F F 1.90 (0.20; 18.1) 0.58
FFA (mmol l1) F F F F 1.42 (0.48; 4.26) 0.52
Fibrinogen (g l1) F F 1.00 (0.99; 1.02) 0.54 F F
ASAT (IU l1) F F 0.66 (0.37; 1.19) 0.17 F F
Leptin (ng ml1) 1.17 (0.94; 1.47) 0.17
Derived indices
BIGTT-SI F F F F 0.89 (0.73; 1.07) 0.21
BIGTT-AIR F F F F 1.17 (0.89; 1.54) 0.25
Rs17700633
Metabolic traits
p-Glucose (10mmol l1) 0.64 (0.29; 1.43) 0.27 1.01 (0.98; 1.05) 0.54 1.22 (0.36; 4.16) 0.75
s-Insulin (50 pmol l1) F F F F 1.25 (1.02; 1.54) 0.030
s-HDL (mmol l1) 0.84 (0.55; 1.28) 0.41 0.72 (0.57; 0.92) 0.008 0.64 (0.35; 1.14) 0.13
s-Triglycerides (10mmol l1) F F F F 1.83 (0.43; 7.84) 0.41
Systolic BP (10mmHg) 0.99 (0.92; 1.07) 0.83 1.05 (0.99; 1.11) 0.10 0.99 (0.89; 1.09) 0.76
Diastolic BP (10mmHg) 1.01 (0.92; 1.10) 0.92 1.05 (0.96; 1.14) 0.27 0.97 (0.83; 1.13) 0.68
s-C-peptide (500mmol l1) F F F F 1.25 (0.98; 1.58) 0.07
HbA1C (%) F F F F 1.89 (0.20; 18.3) 0.58
FFA (mmol l1) F F F F 0.46 (0.16; 1.37) 0.16
Fibrinogen (g l1) F F 1.00 (0.98; 1.01) 0.47 F F
ASAT (IU l1) F F 1.08 (0.62; 1.89) 0.79 F F
Leptin (10 ng ml1) 1.42 (1.12; 1.82) 0.005
Derived indices
BIGTT-SI F F F F 0.81 (0.67; 0.99) 0.038
BIGTT-AIR F F F 1.27 (0.96; 1.66) 0.09
Abbreviations: BIGTT-AIR, OGTT-derived index of acute insulin response; BIGTT-SI, OGTT-derived index of insulin sensitivity; BP, blood pressure; HbA1C, glycated
hemoglobin; HDL, high-density lipoprotein; p, plasma; s, serum. S-35, S-46 and S-49 denote the separate surveys in which participants were examined at the mean
age of 35, 36 and 49 years, respectively. S-35, S-46 and S-49 denote the separate surveys, in which participants were examined at the mean age of 35, 36 and 49
years, respectively. Within each survey, the obese and the control group were analysed together by using the phenotype, for example body mass index (BMI), as
covariate in a logistic regression model with odds of the genotype as the response variable. All analyses were adjusted for age. aAll values for the S-49 are derived
from the oral glucose tolerance test (OGTT) examination, and are therefore fasting compared to non-fasting for S-35 and S-46. The units of the covariates were
chosen to make the odds ratios readable with significant digits even though this results in unrealistic unit values.
Table 4 Odds ratio (OR) including 95% confidence intervals (CI) for MC4R rs17782313 C-allele carriers and for rs17700633 A-allele carriers in relation to birth
weight and age-adjusted BMI z-scores at childhood and adolescence
Rs17782313 P Rs17700633 P
OR (95% CI) OR (95% CI)
Birth weight, n¼ 329 1.01 (0.82; 1.23) 0.95 1.04 (0.85; 1.27) 0.69
BMI z-score of:
7 years, n¼ 382 1.08 (0.98; 1.20) 0.14 1.15 (1.03; 1.28) 0.015
10 years, n¼381 1.11 (0.99; 1.23) 0.07 1.17 (1.05; 1.30) 0.005
13 years, n¼373 1.12 (1.01; 1.25) 0.04 1.17 (1.05; 1.30) 0.005
19 years, n¼1 621 1.07 (1.03; 1.11) 0.0004 1.04 (1.00; 1.08) 0.038
Abbreviation: BMI, body mass index. Within each age, the obese and the control group were analysed together by using the phenotype, e.g. BMI, as covariate in a
logistic regression model with odds of the genotype as the response variable.
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Energy expenditure
None of the two variants near MC4R were significantly
associated with resting energy expenditure, leisure-time
physical activity, VO2max or glucose-induced thermogenesis
(Table 5).
Discussion
The present case–cohort study of Danish men assessed at
upto eight points in time confirmed associations of
rs17782313, rs17700633 and rs12970134 near MC4R with
human fatness from childhood through middle age. As
rs12970134 was in high LD with rs17782313 (r2¼0.75), all
results were identical for these two single-nucleotide poly-
morphisms. Carriers of the rs17782313 C-allele were more
frequently observed the greater the BMI and the larger the
waist circumference than carriers homozygous for the major
allele. Similar associations were observed for carriers of the
rs17700633 A-allele compared with carriers homozygous for
the major allele. Although previous studies have suggested
additive effects of the minor alleles, our data suggested that a
dominant pattern fitted better to the data, which may be due
to the manifold enrichment of the sample in the upper tail
of the BMI distribution. Except for associations for
rs17700633 with circulating HDL-cholesterol, leptin and
insulin and with a surrogate measure of insulin sensitivity
(BIGTT-SI), all most likely explained by effect of fat-BMI,
there were no consistent and significant relations to
metabolic traits.
The rs17782313 C-allele near MC4R was associated with
overall (BMI, fat-BMI), abdominal (waist circumference,
intra-abdominal adipose tissue) and peripheral (hip circum-
ference, lower body fat mass) fatness. The strength of the
associations between the SNPs and the various fatness
phenotypes was about equal throughout the range of each
phenotype at survey S-46 and S-49 and comparable to
previously reported studies.10 Although estimates were
similar, the results from S-49 did not reach statistical
significance, except for peripheral fatness. Compared with
rs17782313, stronger significant associations were obtained
at S-49 between the A-allele of rs17700633 near MC4R and
overall, abdominal and peripheral fatness, but not at the
preceding surveys. All the associations were weakened when
adjusted for fat-BMI and became statistically non-significant.
To partial out any fat-BMI independent effects of the near
MC4R variants on the various body fat distribution measures
would require greater statistical power.
Associations were observed between rs17782313 and HDL-
cholesterol levels, and between MC4R rs17700633, plasma
insulin, serum HDL-cholesterol, circulating leptin and
insulin sensitivity. As expected, adjusting for fat-BMI
weakened these associations. However, as for body fat
distribution, greater statistical power is needed to convin-
cingly discern fat-BMI independent effects. The results are
analogous to the association of a common FTO variant
(rs9939609) with type 2 diabetes.3–5,22 However, in our study,
associations with plasma insulin and insulin sensitivity were
obtained for rs17700633, which is in contrast to other
studies that report associations between insulin measures
and rs17782313 and/or rs12970134.11,23,24 The mediating
effect of fat-BMI on metabolic traits and type 2 diabetes seem
to be less clear across different populations.10,11,24 It is to be
noted that except for associations with HDL-cholesterol,
insulin, insulin-sensitivity and leptin, none of the other
obesity-associated metabolic traits were significantly asso-
ciated with the near MC4R variants.
We observed stronger associations for rs17700633 than
with rs17782313, which is not in line with previous
studies.10,11,24 Rs17782313 near MC4R has been reported to
be the most significantly associated variant,10 and most
studies do not report significant associations for
rs17700633.10,11,24 One recent study, however, has reported
associations between rs17700633 and obesity phenotypes,
but not with metabolic traits.23 In the same study, the results
for rs17782313 were abolished when the effect of rs12970134
was taken into account, whereas rs12970134 and rs17700633
seemed to have independent effects, which is analogous to
our results. A potential explanation is that rs17700633 near
Table 5 Odds ratio (OR) including 95% confidence intervals (CI) for MC4R
rs17782313 C-allele carriers and for rs17700633 A-allele carriers. In relation to
resting energy expenditure (n¼ 547), LTPA (n¼541), VO2max (n¼463) and




Resting energy expenditure (MJ) 1.37 (0.82; 2.29) 0.23
LTPA
o2h light PA per week 1.00 0.78a
2–4 light PA per week 1.25 (0.70; 2.25) 0.45
44h light or 2–4 h moderate PA per week 1.05 (0.57; 1.95) 0.77
44h moderate PA per week 1.15 (0.42; 3.10) 0.92
VO2max (lmin
1) 1.07 (0.76; 1.50) 0.70
Glucose-induced thermogenesis 1.05 (0.90; 1.21) 0.55
Rs17700633
Resting energy expenditure (MJ) 1.24 (0.74; 2.07) 0.41
LTPA
o2h light PA per week 1.00 0.63a
2–4 light PA per week 0.92 (0.52; 1.64) 0.40
44h light or 2–4 h moderate PA per week 1.16 (0.63; 2.13) 0.56
44h moderate PA per week 1.14 (0.42; 3.08) 0.80
VO2max (lmin
1) 1.03 (0.73; 1.44) 0.87
Glucose-induced thermogenesis (MJ) 1.05 (0.91; 1.22) 0.53
Abbreviations: MJ, mega Joule; l, liter; LTPA, leisure-time physical activity; MJ,
mega Joule. S-49 denotes the survey in which participants were examined at
the mean age of 49 years. The obese and the control group were analysed
together by using the phenotype, for example body mass index (BMI), as
covariate in a logistic regression model with odds of the genotype as the
response variable. All analyses were adjusted for age. aP for monotonic trend.
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MC4R may have a more pronounced effect on extreme
obesity. This means, that studies, in which the extreme
ranges of the obesity phenotypes are not represented, may
not be able to detect such an association.
Analysis from the school health records of the participants
revealed that the rs17782313 C-allele MC4R was associated
with BMI z-score in childhood and adolescence, though only
statistically significant at ages 13 and 19 years. The MC4R
rs17700633 A-allele was associated with BMI z-score in both
childhood and adolescence (age 7, 10, 13 and 19 years).
Combined with the results obtained during adulthood, it
appears that these variants have a considerable impact
on body weight from childhood though adulthood. No
associations were obtained for birth weight, which is in
agreement with a previously reported study.10 As rare
severe coding mutations in MC4R are associated with
increases in lean body mass, bone mineral density and
enhanced linear growth,25 it may be of interest to examine
associations with body weight changes and linear growth in
a future study.
The examined variants were in our study not associated
with resting energy expenditure, leisure-time physical
activity, VO2max or glucose-induced thermogenesis. These
results suggest that the examined variants may not be
associated with energy expenditure. Rs17782313 near
MC4R has recently been associated with higher energy and
fat intake.24 Experimental data show that MC4R may have a
role in controlling fat intake preferences,26 but the mechan-
isms underlying these observations need to be further
elucidated.
The strengths of the present population-based study of
Danish Caucasian men include the sampling design, where-
in the controls were randomly selected from the same
population in which the cases were identified and
followed up for approximately 30 years. Repetitive detailed
assessment of anthropometric and physiological variables at
mean ages 35, 46 and 49 years, and the possibility of linking
data on BMI from school health records for the same
individuals makes the present study population unique and
appropriate for investigating the impact of gene variants on
body weight development. In addition, fatness was exam-
ined through a broad range of fatness and at the age of
inclusion, the obese participants represented the most
extreme range of the fatness phenotypes, above the 99th
percentile.
However, several limitations need to be acknowledged.
The sampling design does not allow the usual simple
estimation of distribution parameters for the phenotypes
for given genotypes, for example mean BMI per genotype.
Population stratification may occur because of systematic
admixture of ancestry, and may lead to spurious associa-
tions.27 However, population stratification is unlikely to
explain the obtained results because of the homogenous
study population of Danish Caucasian men, in which the
examined genotype distributions complied with Hardy–
Weinberg equilibrium. The observed effect sizes may seem
relatively small, and may be too small to disentangle fat-BMI
dependent and independent components. However, the
effects may still have impact on health; in a recent large
population-based study, a surprisingly little increase in body
weight throughout the range of body weights was associated
with increases in risk of coronary heart disease.28 As the
findings of this study are restricted to men, the findings need
to be replicated in other populations. Potential sex-related
effects have been suggested and results from a study suggest
that their obtained association between rs17782313 MC4R
and type 2 diabetes may be more evident in women.24 The
examined genotypes show almost similar distribution for the
minor allele frequencies and, hence, argue against that the
attrition of the samples from the three surveys is related to
the particular examined associations. The present sample
size may seem small for a genetic association study, and
especially the threefold drop in sample size from S-46 to S-49
may have reduced the statistical power. Precision of the
measurement may also reduce the statistical power, for
example measurements of abdominal obesity and amount of
visceral fat, although usable,29 might have been much better
using more advanced imaging technology, such as computed
tomography scanning and nuclear magnetic resonance
imaging. On the other hand, keeping the phenotypes as
quantitative variables in the analyses, the efficiency is
considerably higher than in usual case–control type of
analysis, as reflected in the fairly narrow confidence inter-
vals; this means that we thereby have narrowed down the
likely true OR’s that could have given rise to the observed
OR’s. The number of statistical analyses carried out invites
concerns about the possible implications of multiple testing
for the interpretation of the nominal P-values. Valid
adjustment for the multiple testing may not be feasible
because of lack of clear delineation of tests belonging to the
same test series, but caution should be exercised in the
interpretation based on P-values, and major emphasis put on
the consistency of the results, both internally and in
comparison with previous studies.
In conclusion, the results from this study confirmed that
rs17782313, rs17700633 and rs12970134, near MC4R, con-
tribute to individual differences in human fatness during
childhood and adulthood, but not to birth weight. The
A-allele of rs17700633 exhibited somewhat stronger associa-
tions than the C-allele of rs17782313 or the A-allele of
rs12970134, the latter two showing the same associations.
Only few metabolic traits (HDL-cholesterol, insulin, insulin
sensitivity and leptin) were associated with these variants,
and these associations were most likely explained by the
association with fatness.
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